APA (7th ed.) Citation

Q, L., M, D., A, C., CSK, Y., SO, V., S, L., . . . PB, A. (2021). A homozygous stop-gain variant in ARHGAP42 is associated with childhood interstitial lung disease, systemic hypertension, and immunological findings. PLoS genetics, 17(7), e1009639. https://doi.org/10.1371/journal.pgen.1009639

Chicago Style (17th ed.) Citation

Q, Li, et al. "A Homozygous Stop-gain Variant in ARHGAP42 Is Associated with Childhood Interstitial Lung Disease, Systemic Hypertension, and Immunological Findings." PLoS Genetics 17, no. 7 (2021): e1009639. https://doi.org/10.1371/journal.pgen.1009639.

MLA (9th ed.) Citation

Q, Li, et al. "A Homozygous Stop-gain Variant in ARHGAP42 Is Associated with Childhood Interstitial Lung Disease, Systemic Hypertension, and Immunological Findings." PLoS Genetics, vol. 17, no. 7, 2021, p. e1009639, https://doi.org/10.1371/journal.pgen.1009639.